Cargando…
Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases
BACKGROUND: With acute myeloid leukemia (AML), there are limited data about the accuracy of day 14 bone marrow (BM) biopsies for predicting complete remission as compared to day 28 BM biopsy results. We here aimed to estimate the correlation between, and the diagnostic accuracy of, both approaches....
Autores principales: | Alsaleh, Khalid, Aleem, Aamer, Almomen, Abdulkareem, Anjum, Farhan, Alotaibi, Ghazi S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980929/ https://www.ncbi.nlm.nih.gov/pubmed/29479992 http://dx.doi.org/10.22034/APJCP.2018.19.2.421 |
Ejemplares similares
-
Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy
por: Souto Filho, João Tadeu D, et al.
Publicado: (2015) -
Vanishing Bile Duct Syndrome in a Hodgkin's Lymphoma Patient with Fatal Outcome Despite Lymphoma Remission
por: Aleem, Aamer, et al.
Publicado: (2013) -
Acute Lymphoblastic Leukemia Presenting with Liver Infiltration and Severe Lactic Acidosis
por: Sayyed, Ayman Hassan, et al.
Publicado: (2018) -
Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023) -
Bone Marrow Biopsy
por: Haworth, C.
Publicado: (1982)